Perrigo Company  (PRGO) Trade Now »     Rate PRGO  -  Discuss PRGO  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

PRGO Analysis & Videos »


PRGO: Bull or Bear?

Bullish on PRGO ... PRGO

N/A

+44.22% in 196 days Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and consumer products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segmen... Continue reading »

By  supratrader   (+14.97%  risk: conservative)  05/10/09

Comment

Bullish on PRGO ... PRGO

62%

+103.59% in 258 days Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and consumer products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segmen... Continue reading »

By  Marian Filo   (-24.55%  risk: aggressive)  03/09/09

Comment

Healthcare Investing Trends in '09 and Beyond PRGO

73%

+59.55% in 288 days Healthcare Investing Trends for '09 and Beyond <> While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector. Global Health IT : The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a pro< />< />< />< /><>< />< />< />< /><><>< />< /><>< />< />< />< /><>... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  02/07/09

Comment

Five Top Rated Healthcare Cost Containment Stocks PRGO

73%

-22.94% in 38 days (closed on 02/07/09) The table at my website link below includes statistics and the top five rated companies in the ETF Innovators [ETFI] Global Healthcare Cost Containment Index. The index includes generic drug companies such as Teva Pharma (TEVA) and Perrigo (PRGO) as well as pharmacy benefit managers such as Express Scripts (ESRX), which share the common theme of promoting the use of generics to lower healthcare costs. http://www.etfinnovators.com/2008/12/five-top-rated-healthcar... <> <> The Top 40 Rated companies outpaced the overall market and benchmark healthcare ETFs over the past year w... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  12/30/08

Comment

Have Your Say on Healthcare Reform PRGO

73%

-3.51% in 23 days (closed on 12/30/08) Have Your Say on Healthcare Reform <> Visit the Change.gov website to submit your ideas on healthcare reform as the new Obama-Biden administration prepares for their inauguration on January 20, 2009. Tom Daschle will serve as Secretary of Health & Human Services and is encouraging the nation to share their healthcare experiences and suggestions to improve and reform healthcare in the U.S. A key feature of the plan is making health insurance coverage possible for all Americans using the existing network of insurers and providers. The plan relies on tax credits for sm... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  12/07/08

Comment

Generic Cardio Drugs Equal Brands - JAMA PRGO

73%

+2.32% in 5 days (closed on 12/07/08) Generic Cardio Drugs Equal Brands - JAMA <> A meta-analysis review of clinical studies published in peer-reviewed journals was featured today in The Journal of the American Medical Association [JAMA] and concluded that cost-saving generics used to treat a variety of cardiovascular conditions produced equivalent clinical outcomes to higher cost brand name drugs. Despite this clinical evidence, the review notes that a majority (53%) of the 43 editorials analyzed had a negative opinion on generic substitution. While there are currently no ETFs on the market w... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  12/02/08

Comment

Health Cost Containment Index: Expanded into India, Impax Labs to Re-List PRGO

73%

-6.16% in 5 days (closed on 12/02/08) Health Cost Containment Index: Expanding into India, Impax Labs Set to Re-List <> The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table is updated and expanded to include more companies from my recent Analysis of Generic Drug Companies from India . The index is structured to include companies with market caps between $150M-$60B, which are involved in producing generic healthcare products such as generic drugs and pharmacy benefit managers which do not have retail store and insurance components. The Top 10 ... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/27/08

Comment

A New Global Healthcare Composite Index PRGO

73%

+11.55% in 4 days (closed on 11/27/08) A New Global Healthcare Composite Index <> The accompanying table [click to enlarge or download] presents the top five rated companies with market caps of at least $250M from each of the 10 new healthcare indexes developed by ETF Innovators [ETFI] from a database of about 500 companies worldwide. The ETFI Global Healthcare Sector PerformIdex consists of 50 top rated companies on an equal weight basis from each of the 10 new healthcare indexes as an alternative strategy to existing health composite ETFs with highly correlated returns and over-weight exposure to th... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/23/08

Comment

Stock Picks for a 'Roadhouse Blues' Market PRGO

73%

+2.02% in 2 days (closed on 11/23/08) Stock Opportunities in a 'Roadhouse Blues' Market <> The fear and pessimism behind major selling pressure and stock market losses can be summarized by the late Jim Morrison in a song by The Doors called 'Roadhouse Blues' – "The future's uncertain, and the end is always near." Some stocks that I follow which are trading at less than half of the 20% decline for the S&P 500 ETF (SPY) below its 50-day moving average are highlighted below. Earlier this week, AspenBio Pharma (APPY) reported that its key clinical trial was nearly 90% enrolled for AppyScore, which is a blood-... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/21/08

Comment

A New Index of Healthcare Cost Containment Companies PRGO

73%

-6.70% in 1 day (closed on 11/21/08) A New Index of Healthcare Cost Containment Companies <> <> The ETF Innovators [ETFI] Global Healthcare Cost Containment Index profiled in the accompanying table includes companies with market caps over $250M which are involved in the following two segments of the healthcare sector with the common theme of reducing healthcare costs and insurance premiums for consumers, employers, and third-party payers such as the government (through Medicare recipients) and insurance companies. Generic Healthcare Products: This category includes generic prescription a... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/20/08

Comment

Cosmetic & Reconstructive Medicine Companies Outpace the Healthcare Sector PRGO

73%

-6.01% in 19 days (closed on 11/20/08) Cosmetic & Reconstructive Medicine Companies Outpace the Healthcare Sector <> <> The accompanying table presents the statistics and seven highest rated companies from the ETFI Global Cosmetic and Reconstructive Medicine [CRM] Index, which includes companies with market caps over $100M engaged in prescription skin care treatments, weight loss, cosmetic medicine, regenerative medicine, orthopedic repair, and joint replacements. Over the past year, the CRM Index fared better than the Healthcare Sector SPDR (XLV) and the S&P 500 SPDR (SPY) for the top 30 rated companies a... Continue reading »

By  Mike Havrilla   (+1.04%  risk: conservative)  11/01/08

Comment

Bullish on PRGO ... PRGO

16%

+21.16% in 709 days Aggressive Growth – Perrigo Company (Nasdaq: PRGO) "Perrigo just received some great news from the FDA about a heartburn drug. That gave the shares a nice boost. The company also reported excellent fiscal first-quarter earnings. Perrigo has posted an average surprise of 12.1% over the past four quarters. Over the past 60 days, this year's earnings estimates have risen 13 cents to $1.24 per share." http://chicago.dbusinessnews.com/shownews.php?newsid=144361&a... http://fdanews.com/newsletter/article?issueId=11141&artic... <> Revenue rose 12% to $382.7 million from $340.... Continue reading »

By  J Alex   (-18.11%  risk: moderate)  12/13/07

Comment

People Bullish on PRGO

supratrader Principal N/A 6 mos ago	Marian Filo Principal 62% 8 mos ago	Mike Havrilla Principal 73% 9 mos ago
steluci Analyst 36% about 1 year ago	mike2004stocks Analyst N/A about 1 year ago

People Bearish on PRGO

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.